Interactions between cannabidiol and commonly used antiepileptic drugs
- T. Gaston, E. Bebin, G. Cutter, Yuliang Liu, J. Szaflarski
- Biology, MedicineEpilepsia
- 1 September 2017
To identify potential pharmacokinetic interactions between the pharmaceutical formulation of cannabidiol (CBD; Epidiolex) and the commonly used antiepileptic drugs (AEDs) through an open‐label safety…
Cannabis for the Treatment of Epilepsy: an Update
- T. Gaston, J. Szaflarski
- Medicine, BiologyCurrent Neurology and Neuroscience Reports
- 8 September 2018
Understanding of CBD’s efficacy and safety in the treatment of TRE has expanded significantly in the last few years, and data from both open-label expanded access programs (EAPs) and randomized placebo-controlled trials (RCTs) of a highly purified oral preparation of CBD are presented.
Pharmacology of cannabinoids in the treatment of epilepsy
- T. Gaston, D. Friedman
- Biology, MedicineEpilepsy & Behavior
- 1 May 2017
Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- J. Szaflarski, E. Bebin, L. V. Ver Hoef
- MedicineEpilepsy & Behavior
- 1 October 2018
Drug–drug interactions with cannabidiol (CBD) appear to have no effect on treatment response in an open-label Expanded Access Program
- T. Gaston, E. Bebin, J. Szaflarski
- Psychology, MedicineEpilepsy & Behavior
- 2 August 2019
White matter diffusion abnormalities in patients with psychogenic non-epileptic seizures
- Seongtaek Lee, J. Allendorfer, L. W. Hoef
- Medicine, PsychologyBrain Research
- 16 September 2015
De Novo Status Epilepticus in patients with COVID‐19
- Sana Somani, S. Pati, T. Gaston, Alissa Chitlangia, Shruti P. Agnihotri
- MedicineAnnals of Clinical and Translational Neurology
- 14 May 2020
A single‐center retrospective case series reporting the EEG and outcome of de novo status epilepticus (SE) in two African‐American women with laboratory‐confirmed SARS‐CoV‐2 virus is presented.
Quality of life in adults enrolled in an open-label study of cannabidiol (CBD) for treatment-resistant epilepsy
- T. Gaston, M. Szaflarski, B. Hansen, E. Bebin, J. Szaflarski
- Psychology, MedicineEpilepsy & Behavior
- 1 June 2019
Cannabidiol normalizes resting-state functional connectivity in treatment-resistant epilepsy
- R. Nenert, J. Allendorfer, J. Szaflarski
- Psychology, BiologyEpilepsy & Behavior
- 30 July 2020
White matter integrity after cannabidiol administration for treatment resistant epilepsy
- J. Houston, R. Nenert, J. Szaflarski
- MedicineEpilepsy Research
- 8 March 2021
...
...